These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15230126)

  • 1. [Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak DV; Kuznetsova TV; Kobylianskiĭ AG; Kliukvina NG; Reshetniak TM; Nasonov EL
    Ter Arkh; 2004; 76(5):19-22. PubMed ID: 15230126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Soluble adhesion molecules in antiphospholipid syndrome associated with systemic lupus erythematosus and in primary antiphospholipid syndrome].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina NG; Reshetniak DV; Samsonov MIu; Nasonov EL
    Ter Arkh; 2002; 74(5):23-7. PubMed ID: 12087900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Shirokova IE; Lisitskaia TL
    Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
    Aleksandrova EN; Novikov AA; Popkova TV; Reshetniak TM; Novikova DS; Kliukvina NG; Il'ina AE; Mach ES; Volkov AV; Nasonov EL
    Ter Arkh; 2006; 78(6):35-9. PubMed ID: 16881361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
    Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Lisitsyna TA; Nasonov EL
    Klin Med (Mosk); 2004; 82(6):46-51. PubMed ID: 15344691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid syndrome and exogenic risk factors in thromboses].
    Tikhonova TL; Mach ES; Shirokova IE; Reshetniak TM
    Ter Arkh; 2004; 76(11):71-4. PubMed ID: 15658543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome.
    Maymon R; Sehmi IK; Herman A; Jones RG; Sherman D; Cuckle H
    Prenat Diagn; 2000 Jan; 20(1):12-6. PubMed ID: 10701844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
    Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary dysfunction in systemic lupus erythematosus and anti-phospholipid syndrome patients.
    Paran D; Fireman E; Levartovsky D; Elkayam O; Kaufman I; Litinsky I; Caspi D; Koifman B; Keren G; Schwarz Y
    Scand J Rheumatol; 2007; 36(4):285-90. PubMed ID: 17763206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.